Although, vascular CXCL12 expression was found independent of NB clinical stages (Table S1), it increased in tumors from patients over one year-old, whom are known to potentially present aggressive tumors [2] (Figure 1F). This evidence concerns the gene CXCL12 and neuroblastoma.